INTRODUCTION Alopecia areata (AA) is a common autoimmune disorder marked by unpredictable, non-scarring hair loss on the scalp, face and body that can cause significant emotional and psychosocial distress.1, 2 Though patients with severe AA have a poor prognosis, with high rates of treatment failure and relapse,3, 4 Janus kinase (JAK) inhibitors have recently emerged as promising therapies.5, 6 The oral, selective and reversible JAK1/JAK2 inhibitor baricitinib is the first systemic treatment...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with A.
Contact A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack